NKI has a strong academic collaboration with NYU Langone Medical Center and the NYU School of Medicine, well known for its tradition of integrating patient care, research and education. Founded in 1841, the School of Medicine includes the Joan and Joel Smilow Research Center, devoted to translational (patient-oriented) medicine; the Skirball Institute of Biomolecular Medicine, a basic research facility; the Sackler Institute of Graduate Biomedical Sciences, which offers interdisciplinary training programs in the basic medical sciences, leading to the Ph.D. degree; and the NYU Post-Graduate Medical School, offering continuing medical education courses to physicians and other biomedical health professionals. NYU School of Medicine was placed on the honor roll and ranked top 15 in the country and number 2 in New York on the 2016 US News and World Report’s best graduate schools. In the last year alone, NYU performed research leading to more than 4,000 scientific publications and trained more than 700 future physicians.
Within the NYU network, NKI has a close affiliation with the Department of Psychiatry. Since its inception, the Department of Psychiatry has grown into one of the largest clinical departments at NYU. Rich in both research and clinical areas with current focus on brain aging, schizophrenia, and addiction, the NYU Department of Psychiatry is a recognized leader in research, with research faculty and staff who are experts in their fields of inquiry.
Affiliations within the Nathan Kline Institute
The Center for Dementia Research is located within the Nathan S. Kline Institute for Psychiatric Research (NKI), a facility of the New York State Office of Mental Health that has earned a national and international reputation for its pioneering contributions in psychiatric research. NKI shares a campus with Rockland Psychiatric Center in Orangeburg, New York (20 miles north of New York City) and receives additional operating support from federal, municipal, and private sources through the Research Foundation for Mental Hygiene.
Geriatric Psychiatry Research Division http://www.rfmh.org/nki/programs/alzheimers.cfm
The Geriatric Psychiatry Research Division, lead by Nunzio Pomara, MD, staffs clinical and experimental research scientists whose work focuses in identifying neurobiological factors associated with vulnerability to drug-induced cognitive toxicity and in the development of progressive cognitive decline and conversion to dementia especially Alzheimer’s disease (AD). The group is also involved in studies to determine if CNS Abeta disturbances are found in cognitively-intact elderly individuals with the depression and if they contribute to the increased risk for AD and to treatment-resistance to conventional antidepressants which have been observed in this population. Through the Memory Education Research Initiative (MERI), a collaborative effort with Rockland County, our group provides free cognitive assessments to individuals with memory concerns and serves as a referral and education source for local professional health workers. Our Division, also severs has a participating site for the federally-Funded ADNI-2 study and for ongoing clinical trials with experimental agents in AD.
Emotional Brain Institute http://www.rfmh.org/nki/programs/ebi.cfm
The goal of EBI is to understand emotions and their impact on mind and behavior across the lifespan. A multi-disciplinary group of researchers is investigating the origins of normal and pathological emotions from the level of mind and behavior to neural systems, cell activity, molecules, and genes. In researching these topics, EBI investigators use state of the art approaches in the study of brain, mind, and behavior. One focus of this research is exploration of how emotional processing changes during normal aging and dementia.
Analytical Psychopharmacology http://www.rfmh.org/nki/facilities/psycho.cfm
The Analytical Psychopharmacology laboratory located within NKI and headed by Thomas B. Cooper, studies biochemical pharmacology in all major psychiatric disorders, with their primary focus on the mode of action of psychotropic drugs and metabolites.